These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34546514)

  • 1. Impact of Nonalcoholic Steatohepatitis on the Outcome of Patients Undergoing Roux-en-Y Gastric Bypass Surgery: a Propensity Score-Matched Analysis.
    Abbassi Z; Orci L; Meyer J; Sgardello SD; Goossens N; Rubbia-Brandt L; Spahr L; Buchs NC; Mönig SP; Toso C; Hagen ME; Jung MK
    Obes Surg; 2022 Jan; 32(1):74-81. PubMed ID: 34546514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease.
    Cherla DV; Rodriguez NA; Vangoitsenhoven R; Singh T; Mehta N; McCullough AJ; Brethauer SA; Schauer PR; Aminian A
    Surg Endosc; 2020 May; 34(5):2266-2272. PubMed ID: 31359195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Function in Patients With Nonalcoholic Fatty Liver Disease Randomized to Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy: A Secondary Analysis of a Randomized Clinical Trial.
    Kalinowski P; Paluszkiewicz R; Ziarkiewicz-Wróblewska B; Wróblewski T; Remiszewski P; Grodzicki M; Krawczyk M
    Ann Surg; 2017 Nov; 266(5):738-745. PubMed ID: 28767558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Roux-en-Y gastric bypass and sleeve gastrectomy on nonalcoholic fatty liver disease: a comparative study.
    Froylich D; Corcelles R; Daigle C; Boules M; Brethauer S; Schauer P
    Surg Obes Relat Dis; 2016 Jan; 12(1):127-31. PubMed ID: 26077701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Roux-en-Y Gastric Bypass Results in Greater Weight Loss at 15-Year Follow-Up Compared with Secondary Roux-en-Y Gastric Bypass After Failure of Gastric Band or Mason McLean Vertical Gastroplasty.
    Etienne JH; Petrucciani N; Goetschy M; Gugenheim J; Schneck AS; Iannelli A
    Obes Surg; 2020 Oct; 30(10):3655-3668. PubMed ID: 32488745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis.
    de Brito E Silva MB; Tustumi F; de Miranda Neto AA; Dantas ACB; Santo MA; Cecconello I
    Obes Surg; 2021 Jun; 31(6):2762-2772. PubMed ID: 33846949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NASH Presence is Associated with a Lower Weight Loss One and 2 Years After Bariatric Surgery in Women with Severe Obesity.
    Sabench F; Bertran L; Vives M; París M; Aguilar C; Martínez S; Binetti J; Real M; Alibalic A; Richart C; Del Castillo D; Auguet T
    Obes Surg; 2022 Oct; 32(10):3313-3323. PubMed ID: 35792995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of 3 bariatric surgery procedures: Roux-en-Y gastric bypass, laparoscopic adjustable gastric band, and sleeve gastrectomy.
    Lee JH; Nguyen QN; Le QA
    Surg Obes Relat Dis; 2016 Jun; 12(5):997-1002. PubMed ID: 27220823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of short or long biliopancreatic limb length after laparoscopic Roux-en-Y gastric bypass surgery for obesity: a propensity score-matched analysis.
    Eckharter C; Heeren N; Mongelli F; Sykora M; Fenner H; Scheiwiller A; Metzger J; Gass JM
    Langenbecks Arch Surg; 2022 Sep; 407(6):2319-2326. PubMed ID: 35536386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Roux-en-Y Gastric Bypass and Sleeve Gastrectomy on Non-Alcoholic Fatty Liver Disease: A 12-Month Follow-Up Study with Paired Liver Biopsies.
    Pedersen JS; Rygg MO; Serizawa RR; Kristiansen VB; Albrechtsen NJW; Gluud LL; Madsbad S; Bendtsen F
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score).
    von Schönfels W; Beckmann JH; Ahrens M; Hendricks A; Röcken C; Szymczak S; Hampe J; Schafmayer C
    Surg Obes Relat Dis; 2018 Oct; 14(10):1607-1616. PubMed ID: 30146425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study.
    Caiazzo R; Lassailly G; Leteurtre E; Baud G; Verkindt H; Raverdy V; Buob D; Pigeyre M; Mathurin P; Pattou F
    Ann Surg; 2014 Nov; 260(5):893-8; discussion 898-9. PubMed ID: 25379859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Bariatric Surgery With Major Adverse Liver and Cardiovascular Outcomes in Patients With Biopsy-Proven Nonalcoholic Steatohepatitis.
    Aminian A; Al-Kurd A; Wilson R; Bena J; Fayazzadeh H; Singh T; Albaugh VL; Shariff FU; Rodriguez NA; Jin J; Brethauer SA; Dasarathy S; Alkhouri N; Schauer PR; McCullough AJ; Nissen SE
    JAMA; 2021 Nov; 326(20):2031-2042. PubMed ID: 34762106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Analysis of Key Genes and Pathways Involved in Nonalcoholic Steatohepatitis Improvement After Roux-en-Y Gastric Bypass Surgery.
    Chen F; Zhou Y; Wu Z; Li Y; Zhou W; Wang Y
    Front Endocrinol (Lausanne); 2020; 11():611213. PubMed ID: 33603714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bariatric Surgery as an Efficient Treatment for Non-Alcoholic Fatty Liver Disease in a Prospective Study with 1-Year Follow-up : BariScan Study.
    Nickel F; Tapking C; Benner L; Sollors J; Billeter AT; Kenngott HG; Bokhary L; Schmid M; von Frankenberg M; Fischer L; Mueller S; Müller-Stich BP
    Obes Surg; 2018 May; 28(5):1342-1350. PubMed ID: 29119336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of NASH with Gastric Bypass.
    Jirapinyo P; Thompson CC
    Curr Gastroenterol Rep; 2018 Sep; 20(10):49. PubMed ID: 30244334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One anastomosis gastric bypass versus Roux-en-Y gastric bypass: a 30-day follow-up review.
    Docimo S; Yang J; Zhang X; Pryor A; Spaniolas K
    Surg Endosc; 2022 Jan; 36(1):498-503. PubMed ID: 33591446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant PPARα and FXR Activation as a Putative Mechanism of NASH Improvement after Gastric Bypass Surgery: a GEO Datasets Analysis.
    Mazzini GS; Khoraki J; Dozmorov M; Browning MG; Wijesinghe D; Wolfe L; Gurski RR; Campos GM
    J Gastrointest Surg; 2019 Jan; 23(1):51-57. PubMed ID: 30206765
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Robotic platform for gastric bypass is associated with more resource utilization: an analysis of MBSAQIP dataset.
    Sharma G; Strong AT; Tu C; Brethauer SA; Schauer PR; Aminian A
    Surg Obes Relat Dis; 2018 Mar; 14(3):304-310. PubMed ID: 29276076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.